Literature DB >> 17263694

Rebound thymic enlargement on CT in adults.

N Yarom1, R Zissin, S Apter, M Hertz, N Rahimi-Levene, G Gayer.   

Abstract

The objective of this study is to report the development of thymic enlargement in adults, mainly associated with chemotherapy for malignancy. The typical CT features of this phenomenon are described. The clinical data and CT studies of 13 adult patients with newly appearing thymic enlargement on CT were reviewed. These patients were followed-up mainly for malignancy. Further follow-up CTs were studied when available. Medical records were reviewed as to the primary disease, its medical treatment and the time of initial appearance of the enlarged thymus in relation to treatment. The study group included 13 adult patients, 12 with malignant disease and one with a slowly resolving pneumonia. The enlarged thymus appeared as a triangular, arrowhead-shaped structure, with a bilobed configuration and convex borders. Density measurements were consistent with homogeneous soft tissue. Location was in the anterior mediastinum, in the normal site of the thymus. In nine patients, follow-up studies were available. The observation period ranged from 5 months to 8 years from the initial appearance of the enlarged thymus. In five of the nine patients, the thymic enlargement resolved after 1-4.5 years. In four of the nine patients, the thymus remained enlarged during a follow-up ranging from 5 months to 2.5 years. Thymic enlargement, while a rare phenomenon in adults, may occur, mainly after chemotherapy. This phenomenon should be included in the differential diagnosis of a soft tissue mass appearing in the anterior mediastinum on follow-up CT in adult patients particularly following treatment for malignancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17263694     DOI: 10.1111/j.1742-1241.2006.00950.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Rebound thymic hyperplasia detected by 18F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer.

Authors:  Tae Joo Jeon; Yong Sang Lee; Jae-Hoon Lee; Hang Seok Chang; Young Hoon Ryu
Journal:  Thyroid       Date:  2014-08-20       Impact factor: 6.568

2.  Assessment of the thymic morphometry using ultrasound in full-term newborns.

Authors:  Ivan Varga; Alexandra Uhrinova; Frantisek Toth; Jana Mistinova
Journal:  Surg Radiol Anat       Date:  2011-03-26       Impact factor: 1.246

3.  Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.

Authors:  Ismail Sari; Omer Binicier; Merih Birlik; Servet Akar; Erkan Yilmaz; Aydanur Kargi; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2008-09-23       Impact factor: 2.631

4.  Investigating Factors Associated with Thymic Regeneration after Chemotherapy in Patients with Lymphoma.

Authors:  Dao-Ping Sun; Li Wang; Chong-Yang Ding; Jin-Hua Liang; Hua-Yuan Zhu; Yu-Jie Wu; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

5.  Rebound thymic hyperplasia after bone marrow transplantation in children with haemato-oncological diseases.

Authors:  Taner Arpaci; Barbaros Sahin Karagun
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-23

6.  Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4(+) T cells repopulation.

Authors:  Dao-Ping Sun; Hui Jin; Chong-Yang Ding; Jin-Hua Liang; Li Wang; Lei Fan; Yu-Jie Wu; Wei Xu; Jian-Yong Li
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.